Employment, Work Productivity, and Biologic Treatments in Self-Reported Axial Spondyloarthritis: a Cross-Sectional Study in a Female Predominant Population from the ArthritisPower Registry.
Kelly GaviganW Benjamin NowellTheresa HunterJeffrey R CurtisWilliam N MalatestinicRebecca J BolceJeffrey R LisseJessica WalshPublished in: Rheumatology and therapy (2022)
Although bDMARD treatment rates were similar between employed and not employed participants, disease activity and overall health were better in employed than non-employed participants. Employed participants experienced substantial work productivity impairment due to axSpA.